Top News

In a development that could provide a major boost to Indias medical technology sector a leading US firm is planning to build a giant Research and Development (R&D) campus in tech-hub Bengaluru. According to an official release Stryker Corporation a Michigan-based medical technology company will establish a 140000 square-foot R&D facility in Whitefield Bengaluru to expand its R&D presence in India. What will Strykers R&D facility in Bengaluru do? The new state-of-the-art facility will bring together cross-functional teams and industry-leading lab infrastructure uniquely blending next-generation capabilities in robotics artificial intelligence (AI) digital innovation and product security the release said adding that the facility aims to build on Strykers existing 220000 square-foot R&D campus in Gurugram Haryana. According to the company the new facility will be complemented by a medical experience center and deepen collaboration with healthcare professionals by showcasing solutions that help save lives and improve patient care including ICU beds stretchers ambulance cots and hospital and public-access AEDs (automated external defibrillators). The advanced labs will allow us to work closely with healthcare professionals unlock valuable insights and accelerate innovation. With a strong focus on Digital and AI technologies our new state-of-the-art facility is designed to attract top talent foster excellence and drive sustained growth – all while remaining true to our mission of making healthcare better said Ram Rangarajan Vice President Stryker Global Technology Center as per the release. Bengaluru facility to boost Strykers presence in India Rangarajan said the new R&D facility in Bengaluru will build on Strykers existing presence in India and reflects its continued commitment towards the countrys dynamic ecosystem of research excellence medical technology innovation and deep talent expertise. Based in Kalamazoo Michigan in the US Stryker is regarded a global leader in medical technologies offering innovative products and services in MedSurg Neurotechnology and Orthopedics that impact over 150 million patients annually across the world.